Mathew Blackman
Stock Analyst at Stifel
(4.26)
# 273
Out of 4,829 analysts
59
Total ratings
54.76%
Success rate
14.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.30 | +11.11% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $23.45 | +32.20% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $297.55 | +6.87% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $13.66 | +83.02% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $14.18 | +76.30% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $316.67 | -7.47% | 3 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $59.01 | +59.30% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $12.43 | +93.08% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.36 | +121.40% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $85.05 | +17.58% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $12.67 | +26.28% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.11 | +20.81% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.30
Upside: +11.11%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $23.45
Upside: +32.20%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $297.55
Upside: +6.87%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $13.66
Upside: +83.02%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $14.18
Upside: +76.30%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $316.67
Upside: -7.47%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $59.01
Upside: +59.30%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $12.43
Upside: +93.08%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.36
Upside: +121.40%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $85.05
Upside: +17.58%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $12.67
Upside: +26.28%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.11
Upside: +20.81%